Literature DB >> 17102069

Characteristics of pheochromocytoma in a 4- to 20-year-old population.

Marta Barontini1, Gloria Levin, Gabriela Sanso.   

Abstract

Hypertension in children and adolescents has become a major health problem recently recognized, and in a significant number of patients it is due to an endocrine tumor. The aim of this study was to establish the characteristics of pheochromocytoma in a population of 58 patients between 4 and 20 years of age studied at our Center. They represented a 23% of the total population of 255 pheochromocytoma patients studied. In the younger group (under 20 years of age), there was a marked predominance of severe sustained hypertension (93%), only 7% presented paroxysmal hypertension and none of them was normotensive. The youngsters studied showed a higher incidence of bilateral adrenal pheochromocytoma (34%) and extra-adrenal pheochromocytoma (22%). Malignancy was found in 12% of these patients. In addition, the incidence of familial pheochromocytoma was elevated in these patients (39%). Surprisingly, in contrast with the adult population where the most frequent familial pheochromocytomas were multiple endocrine neoplasia (MEN) type 2A (15%), the younger population showed a higher predominance of von Hippel-Lindau (VHL) (28%) and lower incidence of MEN 2A, MEN 2B, neurofibromatosis (NF), and succinate dehydrogenase subunit B (SDHB). In the VHL group, only two patients belonging to one family, showed the R167W mutation, while the others showed novel mutations in conserved amino acids. It may be speculated that the high incidence of VHL in youngsters may account for the biochemical and clinical features they usually present.

Entities:  

Mesh:

Year:  2006        PMID: 17102069     DOI: 10.1196/annals.1353.003

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  43 in total

Review 1.  Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options.

Authors:  Svenja Nölting; Ashley Grossman; Karel Pacak
Journal:  Exp Clin Endocrinol Diabetes       Date:  2018-09-20       Impact factor: 2.949

2.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

3.  Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population.

Authors:  Abhishek Jha; Alexander Ling; Corina Millo; Garima Gupta; Bruna Viana; Frank I Lin; Peter Herscovitch; Karen T Adams; David Taïeb; Adam R Metwalli; W Marston Linehan; Alessandra Brofferio; Constantine A Stratakis; Electron Kebebew; Maya Lodish; Ali Cahid Civelek; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-04       Impact factor: 9.236

Review 4.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

5.  Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.

Authors:  Ivana Jochmanova; April Melody T Abcede; Ruby Jane S Guerrero; Chandy Lou P Malong; Robert Wesley; Thanh Huynh; Melissa K Gonzales; Katherine I Wolf; Abhishek Jha; Marianne Knue; Tamara Prodanov; Naris Nilubol; Leilani B Mercado-Asis; Constantine A Stratakis; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-15       Impact factor: 4.553

Review 6.  Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.

Authors:  Meredith L Seamon; Ikuyo Yamaguchi
Journal:  Curr Hypertens Rep       Date:  2021-05-27       Impact factor: 5.369

7.  The many faces of pheochromocytoma.

Authors:  H K Ghayee; K L Wyne; F S Yau; W H Snyder; S Holt; S Tunc Gokaslan; F Nwariaku
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 8.  Update on pediatric pheochromocytoma.

Authors:  Bas Havekes; Johannes A Romijn; Graeme Eisenhofer; Karen Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

9.  Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?

Authors:  Tamara Prodanov; Bas Havekes; Katherine L Nathanson; Karen T Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

Review 10.  At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension.

Authors:  Matthew M Grinsell; Victoria F Norwood
Journal:  Pediatr Nephrol       Date:  2008-03-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.